|
Thrombolysis
Citations 61-70 of 134 total displayed.
|
Past content
(since Feb 1998):
|
- Original Contributions
Ximelagatran vs Low-Molecular-Weight Heparin and Warfarin for the Treatment of Deep Vein Thrombosis: A Randomized Trial
- Jean-Noel Fiessinger; Menno V. Huisman; Bruce L. Davidson; Henri Bounameaux; Charles W. Francis; Henry Eriksson; Torbjörn Lundström; Scott D. Berkowitz; Per Nyström; Mona Thorsén; Jeffrey S. Ginsberg; for the THRIVE Treatment Study Investigators
JAMA 2005; 293: 681-689.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation: A Randomized Trial
- SPORTIF Executive Steering Committee for the SPORTIF V Investigators
JAMA 2005; 293: 690-698.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation
- Cara L. O’Brien; Brian F. Gage
JAMA 2005; 293: 699-706.
[Abstract]
[Full text]
[PDF]
- Editorials
Ximelagatran—Promises and Concerns
- Victor Gurewich
JAMA 2005; 293: 736-739.
[Extract]
[Full text]
[PDF]
- Letters
Thrombolysis for Acute Stroke
- Jerry J. Svoboda
JAMA 2005; 293: 421-b-422-b.
[Extract]
[Full text]
[PDF]
- Letters
Predictors of Lack of Improvement After Thrombolytic Stroke Therapy—Reply
- Gustavo Saposnik; Bryan Young; Vladimir Hachinski
JAMA 2005; 293: 421-a.
[Extract]
[Full text]
[PDF]
- Letters
Predictors of Lack of Improvement After Thrombolytic Stroke Therapy
- Andrew Pastewski; Yizhak Kupfer; Sidney Tessler
JAMA 2005; 293: 421.
[Extract]
[Full text]
[PDF]
- Letters
Thrombolysis for Acute Stroke—Reply
- Louis R. Caplan
JAMA 2005; 293: 422.
[Extract]
[Full text]
[PDF]
- Original Contributions
Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation
- The CREATE Trial Group Investigators*
JAMA 2005; 293: 427-435.
[Abstract]
[Full text]
[PDF]
- Editorials
Simple Principles of Clinical Trials Remain Powerful
- Robert M. Califf
JAMA 2005; 293: 489-491.
[Extract]
[Full text]
[PDF]
|
|
